| Literature DB >> 34091712 |
Ramón Lorenzo-Gómez1,2, Rebeca Miranda-Castro1,2, Noemí de-Los-Santos-Álvarez1,2, María Jesús Lobo-Castañón3,4.
Abstract
The role of the extracellular matrix (ECM) remodeling in tumorigenesis and metastasis is becoming increasingly clear. Cancer development requires that tumor cells recruit a tumor microenvironment permissive for further tumor growth. This is a dynamic process that takes place by a cross-talk between tumor cells and ECM. As a consequence, molecules derived from the ECM changes associated to cancer are released into the bloodstream, representing potential biomarkers of tumor development. This article highlights the importance of developing and improving bioanalytical methods for the detection of ECM remodeling-derived components, as a step forward to translate the basic knowledge about cancer progression into the clinical practice.Entities:
Keywords: Aptamer-based assays; Circulating cancer biomarkers; Extracellular matrix; Immunoassays
Mesh:
Substances:
Year: 2021 PMID: 34091712 DOI: 10.1007/s00216-021-03416-2
Source DB: PubMed Journal: Anal Bioanal Chem ISSN: 1618-2642 Impact factor: 4.142